News | October 01, 2014

Siemens Announces First U.S. Installation of Artis one Angiography System

Flexible system installed at Detroit’s St. John Hospital and Medical Center

Siemens Artis one

The Siemens Artis one angiography system

October 1, 2014 — St. Johns Hospital and Medical Center in Detroit recently became the first U.S. healthcare facility to install the Artis one angiography system from Siemens Healthcare. The Artis one is designed to address a broad range of angiographic procedures, from diagnosing and treating coronary artery disease and peripheral vessel occlusions to performing electrophysiology procedures. St. Johns is using the Artis one primarily for interventional cardiology and electrophysiology.

“The compact nature of the Artis one angiography system makes it easy to work with,” said Lingareddy Devireddy, M.D., FACC, CCDS, medical director of cardiology services and chief of cardiology at St. Johns Providence Health System in Warren, Mich. “The footprint of the base and its movement make it easy for left-sided implants, and the system’s peristepping function is convenient for peripheral work.”

Offering a positioning flexibility similar to ceiling-mounted systems, the Artis one occupies 269 square feet, compared to the standard 484 square feet required by ceiling-mounted systems. The Artis one has multiple axes capable of moving independently of one another, enabling easy positioning of the system where needed, regardless of where the user is standing. The system accommodates head-to-toe coverage of patients up to 6 feet, 10 inches without the need for patient repositioning.

Artis one’s Clearstent Live application for interventional cardiology procedures — previously available only with Artis Q and Artis Q.zen — freezes motion in the stent region, allowing the physician to mask out movement of the beating heart and place the stent in precisely the correct position. Cardiac imaging tools of the Artis one include HeartSweep, which uses dual-axis rotational angiography to image the entire heart in one smooth C-arm movement to potentially speed up procedures and save contrast agents. By utilizing 20 percent less energy than the Artis zee floor system, the Artis one also helps reduce operational costs.

For more information: www.usa.siemens.com/artis-one

Related Content

HRS study finds Frequent Coffee Consumption Lowers Chance of Arrhythmias. #HRS #HRS20 Heartrhythm20
News | EP Lab | May 28, 2020
May 28, 2020 – A recent study revealed that drinking a couple of cups of coffee per day does not lead to a greater ri
he Actus AcQMap EP 3-D mapping catheter used  to speed  electromapping and procedure times.

he Actus AcQMap EP 3-D mapping catheter used  to speed  electromapping and procedure times.

News | EP Lab | May 20, 2020
May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of...
Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter.
News | EP Lab | May 19, 2020
May 19, 2020 – Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), an
HRS presentations included BlueSync Evaluation study for Medtronic MyCareLink Heart mobile app and Micra TPS CED Study
News | EP Lab | May 14, 2020
May 14, 2020 – Medtronic announced results from late-breaking clinical trials evaluating the MyCareLink Heart mobile
Etripamil Nasal Spray Does Not Meet Primary Endpoint in Treating Supraventricular Tachycardia in the NODE-301 trial presented at Heart Rhythm 2020. #heartrhythm2020 #HRS2020
News | EP Lab | May 13, 2020
May 13, 2020 — The patient-administered nasal spray drug etripamil did not meet its primary endpoint in treating pati
Medtronic Cobalt and Crome ICD
News | EP Lab | May 12, 2020
May 12, 2020 — Medtronic has received FDA approval for its Cobalt and Crome implantable cardioverter-defibrillators (
The CardioFocus HeartLight Excalibur Balloon X3 ablation system allows direct visualization of the laser ablation procedure, helping reduce use of X-ray angiography and reducing procedure time. FDA clears, approved, the HeartLight X3 Laser Ablation System to Treat Atrial Fibrillation.

The CardioFocus HeartLight Excalibur Balloon X3 ablation system allows direct visualization of the laser ablation procedure, helping reduce use of X-ray angiography and reducing procedure time.

News | EP Lab | May 12, 2020
May 12, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the next-generation CardioFocus Inc.
EP lab photo from Philips Healthcare
News | EP Lab | April 30, 2020
May 1, 2020 — The Heart Rhythm Society (HRS) has created a COVID-19 Task Force to make recommendations related to edu
The European Heart Rhythm Association (EHRA) electrophysiology (EP) annual meeting cancelled due to coronavirus. #COVID19 #coronavirus #2019nCoV
Feature | EP Lab | March 10, 2020 | Dave Fornell, Editor
March 10, 2020 — Novel coronavirus (...
The U.S. Food and Drug Administration (FDA) cleared the Acutus Medical SuperMap, an addition to its AcQMap 3-D imaging and mapping system used to guide electrophysiology (EP) catheter ablation procedures. Adding the SuperMap mode to the AcQMap system enables users to visualize any atrial rhythm in less than three minutes. Rapidly mapping and re-mapping the whole heart chamber facilitates a new procedural workflow in EP ablation, making it practical to execute an iterative "map, ablate, re-map" approach.
News | EP Lab | March 05, 2020
March 5, 2020 — The U.S.